Key result
In women undergoing transcatheter aortic valve replacement, the presence of coronary artery disease without recent percutaneous coronary intervention increased the 1-year risk of the VARC-2 efficacy endpoint compared to those without coronary artery disease.
Why the study?
Although women display a specific risk profile for both PCI and TAVR, the impact of CAD and PCI in women undergoing TAVR was unclear.
Does the presence of coronary artery disease, with or without recent percutaneous coronary intervention, worsen outcomes in women undergoing transcatheter aortic valve replacement?
Observational (n=787)
Yes
Does the presence of coronary artery disease, with or without recent percutaneous coronary intervention, worsen outcomes in women undergoing transcatheter aortic valve replacement?
In women undergoing TAVR, the presence of coronary artery disease, with or without recent PCI, is associated with significantly poorer long-term outcomes including an increased risk of death, MI, or stroke.
Answers are grounded in this paper and cite their sources.
CAD without recent PCI linked to higher post-TAVR events in women; hypothesis-generating and should not yet change practice.
Objectives To evaluate the impact of coronary artery disease (CAD) with or without recent (≤ 30 days) percutaneous coronary intervention (PCI) in women undergoing transcatheter aortic valve replacement (TAVR). Background Although women display a specific risk‐profile for both PCI and TAVR, the impact of CAD and PCI in the setting of TAVR in women is unclear. Methods The multinational Women's International Transcatheter Aortic Valve implantation registry enrolled consecutive female patients undergoing contemporary TAVR in 19 centers between 2013 and 2015. Patients with available coronary angiography or CT scan in the pre‐operative assessment of TAVR were categorized as without CAD, with CAD but no recent PCI and CAD and recent PCI (≤30 days). All events were adjudicated according to the VARC‐2 criteria. Results A total of 787 patients were included in this analysis, among whom 459 (58.3%) had no CAD, 247 (31.4%) had CAD without recent PCI and 81 (10.3%) underwent recent PCI (≤ 30 days before TAVR). After multivariable adjustment, both groups of CAD patients, without and with recent PCI, presented with higher risk of death, myocardial infarction or stroke, compared with patients without CAD (adjHR 1.56, 95%CI 1.03–2.39, P = 0.038 and adjHR 1.96, 95% CI 1.1–3.5, P = .021, respectively). Patients with recent PCI had increased risk of all‐cause death (adjHR 1.89, 95% CI 1.0–3.5, P = 0.04) and stroke (adjHR 3.7, 95% CI 1.0–13.5, P = 0.046) compared with patients without CAD. Conclusion The presence of CAD in women undergoing TAVR, with or without recent PCI, was associated with long‐term poorer outcomes.
No takes yet. Share an insight, caveat, or question.
Guedeney et al. (2018) conducted an observational in Severe and symptomatic aortic stenosis (n=787). Coronary artery disease without recent percutaneous coronary intervention vs. No significant coronary artery disease was evaluated on VARC-2 efficacy endpoint at 1 year (composite of all-cause mortality, all stroke, MI, hospitalization for valve-related symptoms or worsening congestive heart failure) (adjHR 1.8, 95% CI 1.2-2.7, p=0.005). In women undergoing transcatheter aortic valve replacement, the presence of coronary artery disease without recent percutaneous coronary intervention increased the 1-year risk of the VARC-2 efficacy endpoint compared to those without coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: